• Flagellin-based Vaccine for Bubonic Plague

    A new vaccine based on the bacteria-fighting capabilities of the flagellin protein may protect against the bubonic plague. Read more.

  • Ang-1-7

    Wake Forest’s Patricia Gallagher, PhD, and Ann Tallant, PhD, are developing Angiotensin-(1-7) into a powerful, dual fighting chemotherapeutic. Learn more.

  • Innovative Science

    Our scientists are developing tomorrow’s innovations in therapeutics, vaccines, medical devices and more. Get updates from Wake Forest Innovations.

Discover Innovation at Wake Forest

Improving MRI Diagnoses

Improving MRI Diagnoses

Software developed by Wake Forest scientist Youngkyoo Jung, Ph.D., uses Fourier encoded arterial spin labeling to get a faster, clearer and more accurate brain scan.

View More

Better Chemotherapeutic Delivery

Whooping Cough Vaccine

Nanoparticle-induced hyperthermia delivers chemotherapeutic for abdominal cancer treatment quicker and with less damage to surrounding tissue.

View More

Building Better Transistors

Organic Thin Film Transistors

Wake Forest researchers have developed a low-cost, versatile method for making organic thin-film transistors which shows promise for use in the electronics industry.

View More

Partner with Wake Forest

Technology for License

Intellectual Property for License

Wake Forest Innovations offers an extensive portfolio of technology licensing opportunities in biomedical and materials science.

View More

Contract R&D Services

Contract Research & Development Services

Wake Forest Innovations supports your R&D needs through easy access to Wake Forest's unique research capabilities.

View More

Wake Forest Innovation Quarter

Wake Forest Innovation Quarter

Wake Forest Innovations drives the creation of a new hub for innovation in biomedical and materials science and information technology.

View More

News and Highlights

Milestone Reached in Work to Build Replacement Kidneys in the Lab

A new milestone has been reached in regenerative medicine. Wake Forest Institute for Regenerative Medicine scientists have, for the first time, kept blood vessels open and flowing with blood in a replacement kidney study. Lab-grown replacement organs using scaffoldings derived from animal organs have become a widely accepted method in regenerative medicine. The process involves continue reading

Novel Cancer Drug Proves Safe for Leukemia Patients in Phase I Clinical Trial

A novel cancer drug developed by scientists at Wake Forest School of Medicine has successfully completed its Phase I clinical trial. The therapeutic, a unique approach to fighting cancer, aims to shut down or limit the activity of a cancer cell’s mitochondria – the “powerhouse” of the cell. This type of treatment is effective because continue reading

Featured Technology

Compact, Wireless Brain Activity Device

The Universal Brain Activity Transmitter (UBAT), a compact, wireless recording system, analyzes, compresses and transmits individual neural activity data via Bluetooth technology, from distances up to 30 meters. The device has flexible recording capabilities and the capacity for robust transmission in diverse environments. 

Learn more.


Leading and Innovative Technology